Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
British Journal of Pharmacology|August 28, 2007
Prostamides (prostaglandin-ethanolamides) and their pharmacologyD F Woodward, Y Liang, A H-P KraussCardiovascular Drug Reviews|June 5, 2004
Bimatoprost: a novel antiglaucoma agentDavid F Woodward, R L Phelps, A H-P Krauss, et al.Experimental Eye Research|March 2, 2011
A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogsF Impagnatiello, V Borghi, D C Gale, et al.Experimental Eye Research|March 31, 2004
Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependentL Smith-Thomas, M Moustafa, C S Spada, et al.British Journal of Pharmacology|July 1, 2008
Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesY Liang, D F Woodward, V M Guzman, et al.The Journal of Pharmacology and Experimental Therapeutics|February 6, 2004
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolismI Matias, J Chen, L De Petrocellis, et al.The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)D F Woodward, A H-P Krauss, J Chen, et al.Pageof 1